News Danaher Corporation

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2025-06-13 pm EDT			5-day change	1st Jan Change
200.67 ^USD	-2.16%		+4.43%	-12.58%

Jun. 09	Some of the biggest splits in Corporate America	RE
Jun. 09	Some of the biggest splits in Corporate America	RE

Danaher : Sustainability report (Danaher 2025 Sustainability Report)	Jun. 10	PU
Some of the biggest splits in Corporate America	Jun. 09	RE
Some of the biggest splits in Corporate America	Jun. 09	RE
Deutsche Bank Adjusts Danaher Price Target to $235 From $240	Jun. 05	MT
Sciex And Evosep Expand Access To Standardized Proteomics For Pharma And Biotech With New Reseller Agreement	Jun. 02	RE
Software Launches For Sciex Os Ecosystem	Jun. 02	RE
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations	Jun. 02	BU
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement	Jun. 02	BU
SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations	Jun. 02	BU
AstraZeneca, Danaher to Develop New Precision Medicine Diagnostic Tools	May. 30	MT
Danaher partners with AstraZeneca to develop AI diagnostics	May. 30	AN
Danaher Announces Diagnostic Development And Commercialization Partnership To Scale Precision Medicine	May. 29	RE
Danaher, AstraZeneca Collaborate on Precision Medicine	May. 29	MT
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine	May. 29	PR
Danaher Corporation Announces the Launch of Partnership with AstraZeneca to Develop and Commercialize Novel Diagnostic Tools and Tests Intended to Help Clinicians Better Determine Which Patients Would Most Benefit from Precision Medicine Treatments	May. 29	CI
Danaher, AstraZeneca Form Partnership For Diagnostic Development	May. 29	DJ
Third Point LLC Dissolves Share Stake In Meta, Thermo Fisher Scientific & Cuts Share Stake In Microsoft	May. 15	RE
Danaher Corporation Presents at BofA Securities 2025 Healthcare Conference, May-15-2025 10:00 AM	May. 15
Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy	May. 15	BU
Danaher Insider Sold Shares Worth $245,919,391, According to a Recent SEC Filing	May. 14	MT
Proteomics Market worth $60.5 billion by 2029 driven by Rising Tech Innovations	May. 14	AQ
Danaher to Present at Bank of America Securities Healthcare Conference	May. 07	PR
Danaher Keeps Quarterly Dividend at $0.32 per Share, Payable July 25 to Holders of Record June 27	May. 06	MT
Danaher Announces Quarterly Dividend	May. 06	PR
Danaher Announces Regular Quarterly Dividend, Payable on July 25, 2025	May. 06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Danaher Corporation

Equities

DHR

US2358511028

Advanced Medical Equipment & Technology

Filters